Opinion: HIV investments remain no-brainers, but some things need to change

HIV in South Africa is not the crisis it was 20 years ago, and the country faces a growing burden of non-communicable diseases, but specific investments in HIV nevertheless continue to offer excellent value for money for governments and donors alike. As people gather for the 2023 International AIDS Society Conference in Brisbane, Australia, Marcus Low argues that while funding for HIV interventions remains absolutely essential, it is also critical for the future of the HIV response and people living with HIV that HIV should now be better integrated with other healthcare services, especially those for diabetes and hypertension.

Read More

Face to face: “Everything about health is about behaviour”, says Professor Mosa Moshabela

Receiving the Public Health Association’s annual PHILA award recently is one of a string of accolades Professor Mosa Moshabela, Deputy Vice-Chancellor of Research and Innovation at the University of KwaZulu-Natal has under his belt. Biénne Huisman spoke to him about his journey to becoming a doctor and his deep-seated commitment to public health, health innovation, and improving health systems.

Read More

What SA’s COVID-19 experience tells us about NHI

For all the suffering and death the COVID-19 pandemic has caused over the last 12 months, it has arguably also provided a unique opportunity to test some of the mechanisms behind South Africa’s proposed National Health Insurance (NHI) system. The centralised procurement of vaccines and the contracting of doctors, for example, are probably not dissimilar from the arrangements we might see under NHI. Kathryn Cleary asks three leading health experts what lessons, for NHI, we should learn from the COVID-19 response.

Read More